Digene Taps Cytyc's 110 Physician Reps For Hybrid Capture 2 HPV Test
This article was originally published in The Gray Sheet
Executive Summary
Cytyc's 110-person direct sales force focusing on the physician market will offer Digene's Hybrid Capture 2 test for human papilloma virus in conjunction with Cytyc's ThinPrep automated Pap test under a Jan. 18 exclusive co-marketing agreement between the firms.